Introduction: The symptoms of these diseases may go away early when the pregnancy ends, but because of changes in the body, women who have had GDM or preeclampsia are at a significant risk of acquiring type 2 diabetes or persistent hypertension. Materials & Methods: Information about the patient and their medical history was collected, and a general physical and local examination was performed. Patients were assigned treatment based on their blood glucose levels; they received either medical nutritional therapy or a combination of insulin and MNT. Results: There were 15 participants with GDM and PE and 22 participants with GDM without PE in their first pregnancy. In their second pregnancy, there were 10 participants with GDM and PE and 10 participants without PE. In their third pregnancy, there were 3 participants with GDM and PE and 6 participants without PE. In their fourth pregnancy and beyond, there were 2 participants with GDM and PE and 4 participants without PE. The difference was notable (P< 0.05). Conclusion: Considering the negative effects reported in patients with borderline AFI and the lack of clear data and specific guidelines regarding delivery for those with borderline AFI, it is recommended to closely monitor and conduct antepartum surveillance for these patients.